Amgen
Amgen signs Servier deal
July 11, 2013Sales and Marketing Amgen, Servier, heart, procoloran
Amgen has gained rights in the US to two of Servier’s heart drugs: the novel, oral Procoralan and investigational Phase …
Onyx rejects Amgen – seeks new suitors
July 2, 2013Sales and Marketing Amgen, Onyx
Amgen’s advances for Onyx have been knocked back as the biotech firm says it is now seeking new suitors. Onyx …
Amgen moves into Japanese market with Astellas deal
May 29, 2013Sales and Marketing Amgen, Astellas, Vectibix, Zhejiang
Amgen and Astellas have announced a new collaboration that will see them launch five new medicines in Japan from 2016, …
Amgen and Zhejiang sign cancer deal
May 14, 2013Sales and Marketing Amgen, Cancer, Zhejiang
Amgen has signed a joint venture deal with Chinese firm Zhejiang Beta Pharma to commercialise oncology drug Vectibix. The companies …
Amgen earmarks $200m for new Singapore plant
January 18, 2013Manufacturing and Production Amgen, Merck, Singapore
Amgen has unveiled plans to construct a new manufacturing plant in Singapore, its first production facility in Asia. The biotechnology …
$700m fines for Amgen
December 20, 2012Manufacturing and Production, Sales and Marketing Amgen, FDA, off label, off-label
Amgen has pleaded guilty to misbranding its anaemia drug Aranesp following a string of US lawsuits against the biotech company. The …
Amgen appoints Mattel’s Robert Eckert to Board of directors
December 14, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Eckert
Biotech firm Amgen has announced the appointment of Robert Eckert, former chief executive officer at Mattel, to its Board of …
Amgen’s Roger Perlmutter joins Heptares
October 23, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Heptares, Roger Perlmutter
GPCR drug discovery firm Heptares Therapeutics has elected Dr Roger Perlmutter, the former executive VP, Research and Development, at Amgen …
Amgen appoints senior VP and chief compliance officer
October 18, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Cynthia Patton
Amgen has announced the appointment of Cynthia Patton to senior vice president and chief compliance officer. Patton will report to …
Amgen names Ray Jordan senior VP Corporate Affairs
September 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, J&J, JJ, Ray Jordan
Amgen has announced the appointment of ex-J&J comms leader Ray Jordan to the new position of senior vice president, Corporate …
UCB opens Belgian pilot plant
September 17, 2012Manufacturing and Production Amgen, Belgium, R&D, UCB
UCB has officially opened a new pilot biotech plant at its Braine-L’Alleud site in Belgium.The 5,100 sq. m. facility – …
Xgeva gains NICE recommendation for bone metastasis
August 17, 2012Sales and Marketing Amgen, NICE, Xgeva, bone metastatis
NICE is continuing to recommend Amgen’s Xgeva for certain groups of cancer patients whose disease has spread to their bones. …
Amgen unveils plan to close Epogen plant
August 14, 2012Manufacturing and Production Amgen, Epogen, cuts, omontys
Amgen has said it will close down a manufacturing facility in Longmont, Colorado, in the face of declining sales of …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
